These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25530360)

  • 1. Editorial comment.
    Loeb S
    Urology; 2015 Jan; 85(1):21-2. PubMed ID: 25530360
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: To PMID 25444632.
    Yiu MK; Ma WK
    Urology; 2015 Jan; 85(1):22. PubMed ID: 25530361
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum β-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy.
    Tsu JH; Ma WK; Chan WK; Lam BH; To KC; To WK; Ng TK; Liu PL; Cheung FK; Yiu MK
    Urology; 2015 Jan; 85(1):15-21. PubMed ID: 25444632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study.
    Dai J; Leone A; Mermel L; Hwang K; Pareek G; Schiff S; Golijanin D; Renzulli JF
    Urology; 2015 Jan; 85(1):8-14. PubMed ID: 25458193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of beta-lactamases in gram-negative bacilli.
    Wise R; Ashby JP; Piddock LJ
    J Antimicrob Chemother; 1987 Nov; 20(5):767-8. PubMed ID: 3501423
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of Fluoroquinolone Resistant Aerobic Organisms and Efficacy of Rectal Cleaning in Men Undergoing Transrectal Ultrasound Guided Prostate Biopsy.
    Kongubol P; Santanirand P; Sirisreetreerux P; Viseshsindh W; Sangkum P
    J Med Assoc Thai; 2016 Jun; 99(6):691-6. PubMed ID: 29901317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging threat of acquired carbapenemases in Gram-negative bacteria.
    Cornaglia G; Rossolini GM
    Clin Microbiol Infect; 2010 Feb; 16(2):99-101. PubMed ID: 20085603
    [No Abstract]   [Full Text] [Related]  

  • 8. [Correlation between beta-lactamase production and the test of in vitro enzyme induction in 70 strains of gram-negative bacteria isolated in a hospital environment].
    Bovelacci A; Foà-Tomasi L; Ramacciotti PG
    Ann Sclavo; 1982; 24(6):586-95. PubMed ID: 6821296
    [No Abstract]   [Full Text] [Related]  

  • 9. Extended-spectrum beta-lactamases: a brief clinical update.
    Malloy AM; Campos JM
    Pediatr Infect Dis J; 2011 Dec; 30(12):1092-3. PubMed ID: 22105419
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of clavulanic acid sulbactam on induction of class 1 beta-lactamase.
    Farmer TH; Reading C
    J Chemother; 1989 Jul; 1(4 Suppl):331-3. PubMed ID: 16312426
    [No Abstract]   [Full Text] [Related]  

  • 11. High prevalence of co-expression of newer beta-lactamases (ESBLs, Amp-C-beta-lactamases, and metallo-beta-lactamases) in gram-negative bacilli.
    Chatterjee SS; Karmacharya R; Madhup SK; Gautam V; Das A; Ray P
    Indian J Med Microbiol; 2010; 28(3):267-8. PubMed ID: 20644325
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of beta-lactamase production in gram-positive and gram-negative strains by sub-inhibitory concentrations of nalidixic acid.
    Repetto A; Scazzocchio F; Tiecco C; Renzini G
    Chemioterapia; 1984 Oct; 3(5):278-80. PubMed ID: 6335839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of extended spectrum beta lactamases production with cephalosporin resistance in gram negative bacilli.
    Ghatole M; Manthalkar P; Kandle S; Yemul V; Jahagirdar V
    Indian J Pathol Microbiol; 2004 Jan; 47(1):82-4. PubMed ID: 15471144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of carbapenemase-producing Gram-negative bacteria in a single patient linked to the acquisition of multiple carbapenemase producers and to the in vivo transfer of a plasmid encoding VIM-1.
    Drieux L; Bourgeois-Nicolaos N; Cremniter J; Lawrence C; Jarlier V; Doucet-Populaire F; Sougakoff W
    Int J Antimicrob Agents; 2011 Aug; 38(2):179-80. PubMed ID: 21570257
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.
    Rossolini GM; Mantengoli E; Docquier JD; Musmanno RA; Coratza G
    New Microbiol; 2007 Jul; 30(3):332-9. PubMed ID: 17802921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of extended-spectrum beta-lactamases in South America.
    Villegas MV; Kattan JN; Quinteros MG; Casellas JM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():154-8. PubMed ID: 18154539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of extended-spectrum beta-lactamase (ESBL)-producing organisms in blood culture.
    Weinbren MJ; Borthwick MA
    J Antimicrob Chemother; 2005 Jan; 55(1):131-2. PubMed ID: 15574477
    [No Abstract]   [Full Text] [Related]  

  • 18. Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs).
    Giamarellou H
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():1-16. PubMed ID: 15953019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Branhamella catarrhalis--a respiratory tract pathogen with the ability to produce beta-lactamases].
    Malmvall BE
    Lakartidningen; 1984 Oct; 81(43):3931-2. PubMed ID: 6334796
    [No Abstract]   [Full Text] [Related]  

  • 20. [Identification of beta-lactamases of gram-negative bacteria and antibacterial activity of furbenicillin to this strain of bacteria].
    Li JT; Yang YJ
    Zhonghua Yi Xue Za Zhi; 1984 Aug; 64(8):486-9. PubMed ID: 6440695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.